tiprankstipranks
Trending News
More News >
Pharmacorp Rx Inc. (TSE:PCRX)
:PCRX
Canadian Market

Pharmacorp Rx Inc. (PCRX) Financial Statements

Compare
2 Followers

Pharmacorp Rx Inc. Financial Overview

Pharmacorp Rx Inc.'s market cap is currently C$79.50M. The company's EPS TTM is C$-0.004; its P/E ratio is 287.50; Pharmacorp Rx Inc. is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22
Income Statement
Total Revenue
Gross Profit--
Operating Income$ -577.96K$ -563.18K
EBITDA$ -470.43K$ -517.09K
Net Income$ -470.43K$ -517.09K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―
Total Assets$ 2.32M$ 2.73M
Total Debt$ 0.00$ 0.00
Net Debt$ -2.24M$ -2.73M
Total Liabilities$ 46.19K$ 16.46K
Stockholders' Equity$ ―$ ―
Cash Flow
Free Cash Flow$ -519.46K$ -120.18K
Operating Cash Flow$ -519.46K$ -120.18K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Pharmacorp Rx Inc. Earnings and Revenue History

Pharmacorp Rx Inc. Debt to Assets

Pharmacorp Rx Inc. Cash Flow

Pharmacorp Rx Inc. Forecast EPS vs Actual EPS